Skip to main content
MDXG logo

MDXG · Mimedx Group, Inc. · Metrics

Track MDXG — free
$3.86 -0.38 (-8.87%)
Market Cap
$616.57M
Shares
145.76M
Volume · Oct 21 1.02M Avg daily vol (3M) 1.28M

MDXG metrics

97 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.23
Market cap
$616.57M

Price action

20 metrics
Price change (1W)
-9.8%
Price change (30D)
-12.1%
Price change (3M)
-2.1%
Price change (6M)
+32.2%
Price change (YTD)
-37.5%
Price change (1Y)
-37.3%
Trailing year
Price change (5Y)
-40.8%
52-week high
$7.96
52-week low
$3.09
Change from 52-week high
-46.9%
Change from 52-week low
+36.9%
Annualized volatility
40.0%
Annualized volatility (3M)
31.9%
Beta
0.9
RSI (14D)
31.9
Price vs SMA 50
-7.0%
Price vs SMA 200
-3.0%
Avg volume (3M)
1.28M
Relative volume
1.3
Average dollar volume
$5.70M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
145.76M

Valuation

12 metrics
P / E (TTM)
105.8
Trailing earnings · reciprocal yield 0.9%
PEG ratio
—
EV / revenue
1.5×
reciprocal yield 68.3%
EV / EBITDA
—
EV / EBIT
59.4×
reciprocal yield 1.7%
P / sales
1.8×
reciprocal yield 55.6%
P / book
3.0
reciprocal yield 33.8%
FCF yield
—
TTM · current market cap
Buyback yield
2.0%
P / FCF
—
P / operating cash flow
13.8
reciprocal yield 7.2%
Earnings yield
1.0%

Historical valuation

8 metrics
P / E historical average (3Y)
35.6×
reciprocal yield 2.8%
P / E historical average (5Y)
35.6×
reciprocal yield 2.8%
EV / revenue historical average (3Y)
2.4×
reciprocal yield 41.6%
EV / revenue historical average (5Y)
2.3×
reciprocal yield 42.8%
EV / EBIT historical average (3Y)
24.1×
reciprocal yield 4.1%
EV / EBIT historical average (5Y)
24.1×
reciprocal yield 4.1%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-28
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
78.8%
Operating margin
2.5%
Trailing 12 months
Net margin
1.8%
Gross profit (TTM)
$280.05M
Operating profit (TTM)
$8.75M
Net income (TTM)
$6.24M
Trailing 12 months
Diluted EPS (TTM)
$0.04
FCF margin
—
Effective tax rate
45.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$2.38
Gross profit per diluted share (TTM)
$1.87
Operating profit per diluted share (TTM)
$0.06
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.04
Operating cash flow per diluted share (TTM)
$0.31
Free cash flow per diluted share (TTM)
$0.04
Capital expenditures per diluted share (TTM)
$0.02
R&D per diluted share (TTM)
$0.10
Stock compensation per diluted share (TTM)
$0.04
Book value per share
$1.73

Growth

11 metrics
Revenue growth YoY
-34.7%
Year over year
Net income growth YoY
-254.3%
Revenue (TTM)
$355.17M
Trailing 12 months
EPS growth YoY
-266.7%
Shares change YoY
-1.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+16.1%
Revenue CAGR (5Y)
+11.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
2.9%
Return on assets
2.2%
Debt / equity
0.1
Current ratio
5.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
4.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
4.9%
Trailing 12 months
Net cash
$118.63M
Latest balance sheet
Cash & equivalents
$135.84M
Total assets
$281.00M
Total debt
$17.21M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$46.15M
Capital expenditures (TTM)
$1.99M
R&D (TTM)
$15.38M
SG&A (TTM)
$255.08M
Stock compensation (TTM)
$6.59M
R&D / revenue
4.3%
Stock compensation / revenue
1.9%

Ownership (13F)

9 metrics
13F filers
227
13F filer change QoQ
-12
Institutional ownership
76.8%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
45.3%
Private-fund adviser ownership
43.8%
Active holders' share change QoQ
-4.0%
Holder tenure
12.0
Price vs estimated holder cost
-42.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
13.5%

Short interest

3 metrics
Short interest
6.4%
Latest settlement · 7.4 days to cover
Days to cover
7.4d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1376339 CUSIP 602496101 13F (30d) 26 filings 25 filers Visit website Investor relations